16 Mar 2022 by admin in UncategorizedComments Innoforce and Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies
15 Mar 2022 by admin in UncategorizedComments Syros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
15 Mar 2022 by admin in UncategorizedComments Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
10 Mar 2022 by admin in UncategorizedComments Design Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
04 Mar 2022 by admin in UncategorizedComments Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Mar 2022 by admin in UncategorizedComments NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
28 Feb 2022 by admin in UncategorizedComments Design Therapeutics Announces FDA Clearance of Investigational New Drug Application for First GeneTACTM Molecule for Friedreich Ataxia
16 Feb 2022 by admin in UncategorizedComments Walking Fish Therapeutics Closes $73 Million Series A Financing
08 Feb 2022 by admin in UncategorizedComments Arcellx Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares